From 5348fd78a2914a0871e1d187f68041f3142b84d1 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Thu, 21 Mar 2024 15:04:02 +0100 Subject: [PATCH] [logseq-plugin-git:commit] 2024-03-21T14:04:01.693Z --- pages/STOP2030___Web___Posts.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md index 73970809..5375e687 100644 --- a/pages/STOP2030___Web___Posts.md +++ b/pages/STOP2030___Web___Posts.md @@ -1,7 +1,7 @@ # [[WHO]] visit - - # REALISE study registration - - ## Our REALISE study is complete, and published + - ## Our REALISE study design is complete, and published - #+BEGIN_VERSE At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's elimination goals for soil-transmitted helminthiasis (STH). That is why we're happy to announce that we've completed the design of the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness). The details of the trial have been published in clinicaltrials.gov and the Pan African Clinical Trial Registry, and are now ready to be delivered to the Institutional Review Boards (IRBs) in Ghana and Kenya, the two countries were it will be carried out.